Tackling variants with antibodies
Antibodies targeting the protein that causes placental malaria can recognise multiple variants of the protein, which may help guide the development of new vaccines to protect pregnant women from malaria.
Main Authors: | Elizabeth H Aitken, Stephen J Rogerson |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2022-03-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/77751 |
Similar Items
-
A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates
by: Justin YA Doritchamou, et al.
Published: (2022-02-01) -
Pre-clinical and clinical development of the first placental malaria vaccine
by: Caroline Pehrson, et al.
Published: (2017-06-01) -
Reduced risk of placental parasitemia associated with complement fixation on Plasmodium falciparum by antibodies among pregnant women
by: D. Herbert Opi, et al.
Published: (2021-08-01) -
Statistical prediction of immunity to placental malaria based on multi-assay antibody data for malarial antigens
by: Chathura Siriwardhana, et al.
Published: (2017-09-01) -
Progress and Insights Toward an Effective Placental Malaria Vaccine
by: Benoît Gamain, et al.
Published: (2021-02-01)